Xiao et al. [112] coupled anti-PD-1 treatment with CXCR4-targeted p53 mRNA NPs, which successfully promoted complete reprogramming of the immunological TME's molecular and cellular components, thereby reversing immunosuppression in HCC. This evidence concerns the gene CXCR4 and hepatocellular carcinoma.